Alice Šýkorová

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

Heidi Móciková, Robert Pytlík, Alice Šýkorová et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 30 citations

Neuro-oncology, Lymphoid Neoplasia, Medicine +13

Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world

Prokop Vodička, Kateřina Benešová, Andrea Janíková et al. · European Journal Of Haematology · 2022 · 29 citations

Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders

Jana Pospiskova, Lukáš Smolej, David Belada et al. · Orphanet Journal of Rare Diseases · 2019 · 17 citations · Full text

Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study

Martin Hutchings, John Radford, Stephen M. Ansell et al. · Hematological Oncology · 2021 · 17 citations · Full text

Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia

Zdeněk Král, Jozef Michalka, Heidi Móciková et al. · Journal of Cancer · 2019 · 13 citations · Full text